Purpose of review: To summarize ongoing and recently completed trials on geographic atrophy associated with age-related macular degeneration.
Recent findings: A large number of investigational agents are under development for treatment of geographic atrophy in both pre and early-phase clinical testing.
Summary: Therapies targeting all putative phases of pathogenesis in geographic atrophy are under development. Thus far, no therapies have been demonstrated to be effective.